Review Article

Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems

Table 3

Phytochemicals combined with first-line antitumor drugs and their study in clinical trials. Nanocarriers used to enhance bioefficacy of codelivery are also shown.

PhytochemicalCodelivered antitumor agentIn vitro/in vivoClinical trialPhase of studyRef.

Ellagic acid5-FluorouracilColon[279]
VinorelbineHormone refractory prostate cancerCompleted[167]
α-DifluoromethylornithineColon[280]

(−)-Epigallocatechin-3-gallate (EGCG)Tamoxifen + sulindacLung[281]
SulindacIntestinal[281]

GenisteinTamoxifenBreast[282]
Gemcitabine hydrochloridePancreasBreastCompleted[283285]
Osteosarcoma
DecitabinePediatric solid tumors, leukemiaRecruiting[286]
DecitabineNon-small cell lungCompleted[287]
Interleukin-2 (high-dose)Kidney cancerCompleted[288]
Melanoma
5-FluorouracilColon[289]
DocetaxelProstate[290]
Lung
Breast
Pancreas
DoxorubicinProstate[290]
Lung
Breast
Pancreas
CisplatinOvarian[290, 291]
Prostate
Lung
Breast
Pancreas
ErlotinibPancreasCompleted[292]
Erlotinib + gemcitabinePancreasPancreasCompleted[293, 294]

LuteolinCelecoxibBreast[295]

QuercetinDocetaxelProstate[296]
5-FluorouracilEsophageal[297299]
Colorectal
Liver
SulindacColorectalColonCompleted[300]
TamoxifenBreast[301]
PaclitaxelLiver[302]

ResveratrolRapamycinBreast[303]
DoxorubicinBreast[304]
TemozolomideGlioma[305]
5-FluorouracilColon[306]
MitomycinColorectal[307]

CurcuminIrinotecanColorectalColorectalActive[308, 309]
FolfoxColonActive[310]
SulindacLungColorectalCompleted[224, 311]
CapecitabineRectalActive[311]
5-FluorouracilColorectal[312]
DasatinibColon[313]
PaclitaxelBreast[314]
CelecoxibColon[315]
GemcitabineLung[316]
GenisteinProstate[317]

LycopeneDocetaxelProstateAdenocarcinoma of the prostateActive[318, 319]